Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

Hormonal Regulation of Blood Pressure

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparison of fourteen rule-out strategies for acute myocardial infarction.

International journal of cardiology·2018

Same author

Daytime variation of perioperative myocardial injury in non-cardiac surgery and effect on outcome.

Heart (British Cardiac Society)·2018

Same author

Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.

Clinical research in cardiology : official journal of the German Cardiac Society·2018

Same author

Rhabdomyolysis: A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T?

Journal of the American College of Cardiology·2018

Same author

Reply: Hospital Charges Associated With Inpatient Troponin Testing.

Journal of the American College of Cardiology·2018

Same author

Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain.

Clinical chemistry·2018

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Isolation of Atrial Myocytes from Adult Mice

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Natriuretic peptides and their evolving clinical applications.

Markus Noveanu¹, Mihael Potocki, Christian Mueller

¹University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.

Future Cardiology

|October 7, 2009

Summary

Natriuretic peptides (NP) are vital biomarkers for diagnosing heart failure and predicting patient outcomes like death and rehospitalization. Utilizing NP-guided therapy can improve chronic heart failure management and reduce healthcare costs.

More Related Videos

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Related Experiment Videos

Last Updated: Jun 19, 2026

Isolation of Atrial Myocytes from Adult Mice

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Area of Science:

Biomarkers
Cardiology
Clinical Diagnostics

Background:

Natriuretic peptides (NP) are established plasma biomarkers for heart failure (HF).
Current clinical practice widely employs NP for HF diagnosis, especially in dyspneic patients.
NP levels correlate with HF severity and predict adverse outcomes.

Purpose of the Study:

To summarize the role of natriuretic peptides in heart failure diagnosis and management.
To highlight the prognostic value of NP levels in predicting mortality and rehospitalization.
To explore the potential of NP-guided therapy in improving patient outcomes.

Main Methods:

Review of clinical practice guidelines and research on natriuretic peptides.
Analysis of NP utility in diagnosing heart failure in patients with dyspnea.
Evaluation of NP's role in risk stratification for various cardiovascular and pulmonary conditions.

Main Results:

NP are accurate in diagnosing heart failure, particularly in dyspneic individuals.
NP levels effectively quantify disease severity and predict outcomes (death, rehospitalization) in established HF.
NP-guided therapy shows potential to improve morbidity in chronic heart failure.

Conclusions:

Natriuretic peptides are crucial for accurate heart failure diagnosis and prognosis.
NP-guided management strategies offer benefits in reducing costs and improving patient outcomes.
Further research is needed to establish the impact of NP-guided therapy in high-risk patients with other conditions.